Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Jain SU, Khazaei S, Marchione DM, Lundgren SM, et al. Histone H3.3 G34 mutations promote aberrant PRC2 activity and drive tumor progression. Proc Natl Acad Sci U S A 2020;117:27354-27364.
PMID: 33067396


Privacy Policy